Cargando…
Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction
Autores principales: | Akşit, Ercan, Kırılmaz, Bahadır, Gazi, Emine, Aydın, Fatih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285674/ https://www.ncbi.nlm.nih.gov/pubmed/32326691 http://dx.doi.org/10.4274/balkanmedj.galenos.2020.2020.4.100 |
Ejemplares similares
-
A new angiographic finding: primary peripheral slow flow
por: Akşit, Ercan, et al.
Publicado: (2021) -
The importance of statin therapy in atrial fibrillation patients independent of CHADS-VASc score
por: Akşit, Ercan, et al.
Publicado: (2023) -
Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
por: Akman, Canan, et al.
Publicado: (2021) -
Lipoprotein(a): A New Intensive Care Unit Admission Predictor in Coronavirus Disease 2019 Patients
por: Küçük, Uğur, et al.
Publicado: (2023) -
The Importance of Total Neutrophil Count and Neutrophil/Lymphocyte Ratio in ST Elevation Myocardial Infarction
por: Agilli, Mehmet, et al.
Publicado: (2014)